Inicio>>Infectious Disease>> Bacterial Diseases>> Pneumonia>>1-Palmitoyl Lysophosphatidic Acid (sodium salt)

1-Palmitoyl Lysophosphatidic Acid (sodium salt) (Synonyms: 1Palmitoyl LPA)

Catalog No.GC42021

1-Palmitoyl lysophosphatidic acid (1-Palmitoyl LPA) is a LPA analog containing palmitic acid at the sn-1 position.

Products are for research use only. Not for human use. We do not sell to patients.

1-Palmitoyl Lysophosphatidic Acid (sodium salt) Chemical Structure

Cas No.: 17618-08-5

Tamaño Precio Disponibilidad Cantidad
1mg
54,00 $
Disponible
5mg
160,00 $
Disponible
10mg
213,00 $
Disponible
25mg
265,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-Palmitoyl lysophosphatidic acid (1-Palmitoyl LPA) is a LPA analog containing palmitic acid at the sn-1 position. LPA binds to one of five different G protein-coupled receptors (GPCRs) to mediate a variety of biological responses including cell proliferation, smooth muscle contraction, platelet aggregation, neurite retraction, and cell motility. In addition to playing a role in the aforementioned biological responses, 1-palmitoyl LPA enhances the action of β-lactam antibiotics (ampicillin, piperacillin, and ceftazidime) on various strains of Pseudomonas aeruginosa, a pathogen associated with pulmonary disease and pneumonia, via binding both Ca2+ and Mg2+.

Reseñas

Review for 1-Palmitoyl Lysophosphatidic Acid (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Palmitoyl Lysophosphatidic Acid (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.